Insider · CIK 0001578852

Boulding Mark Elliott

Reports to the SEC for 1 company · WARREN, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001578852

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-09	PTCTPTC THERAPEUTICS, INC.M Exercise/Conversion	EXEC. VP AND CLO	MExercise/Conversion	+192 sh	$39.42	+$7,568.64	105,464
2026-10-09	PTCTPTC THERAPEUTICS, INC.S Sale	EXEC. VP AND CLO	SSale	−192 sh	$64.26	−$12.3K	105,272
2026-10-09	PTCTPTC THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	EXEC. VP AND CLO	MExercise/Conversion	−192 sh	—	—	2,267
2026-10-06	PTCTPTC THERAPEUTICS, INC.M Exercise/Conversion	EXEC. VP AND CLO	MExercise/Conversion	+435 sh	$39.42	+$17.1K	105,707
2026-10-06	PTCTPTC THERAPEUTICS, INC.S Sale	EXEC. VP AND CLO	SSale	−435 sh	$64.16	−$27.9K	105,272
2026-10-06	PTCTPTC THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	EXEC. VP AND CLO	MExercise/Conversion	−435 sh	—	—	2,459
2026-10-05	PTCTPTC THERAPEUTICS, INC.M Exercise/Conversion	EXEC. VP AND CLO	MExercise/Conversion	+1,638 sh	$39.42	+$64.6K	106,910
2026-10-05	PTCTPTC THERAPEUTICS, INC.S Sale	EXEC. VP AND CLO	SSale	−1,638 sh	$64.03	−$105K	105,272
2026-10-05	PTCTPTC THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	EXEC. VP AND CLO	MExercise/Conversion	−1,638 sh	—	—	2,894
2026-08-17	PTCTPTC THERAPEUTICS, INC.M Exercise/Conversion	EXEC. VP AND CLO	MExercise/Conversion	+2,813 sh	$25.69	+$72.3K	108,085
2026-08-17	PTCTPTC THERAPEUTICS, INC.S Sale	EXEC. VP AND CLO	SSale	−1,844 sh	$72.39	−$133K	106,241
2026-08-17	PTCTPTC THERAPEUTICS, INC.S Sale	EXEC. VP AND CLO	SSale	−969 sh	$72.90	−$70.6K	105,272
2026-08-17	PTCTPTC THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	EXEC. VP AND CLO	MExercise/Conversion	−2,813 sh	—	—	16,876
2026-07-06	PTCTPTC THERAPEUTICS, INC.M Exercise/Conversion	EXEC. VP AND CLO	MExercise/Conversion	+2,266 sh	$39.42	+$89.3K	107,538
2026-07-06	PTCTPTC THERAPEUTICS, INC.S Sale	EXEC. VP AND CLO	SSale	−313 sh	$83.10	−$26K	107,225
2026-07-06	PTCTPTC THERAPEUTICS, INC.S Sale	EXEC. VP AND CLO	SSale	−833 sh	$84.41	−$70.3K	106,392
2026-07-06	PTCTPTC THERAPEUTICS, INC.S Sale	EXEC. VP AND CLO	SSale	−519 sh	$85.84	−$44.6K	105,873
2026-07-06	PTCTPTC THERAPEUTICS, INC.S Sale	EXEC. VP AND CLO	SSale	−601 sh	$86.38	−$51.9K	105,272
2026-07-06	PTCTPTC THERAPEUTICS, INC.M Exercise/Conversion	EXEC. VP AND CLO	MExercise/Conversion	+2,813 sh	$46.54	+$131K	108,085
2026-07-06	PTCTPTC THERAPEUTICS, INC.S Sale	EXEC. VP AND CLO	SSale	−387 sh	$83.10	−$32.2K	107,698
2026-07-06	PTCTPTC THERAPEUTICS, INC.S Sale	EXEC. VP AND CLO	SSale	−1,036 sh	$84.41	−$87.4K	106,662
2026-07-06	PTCTPTC THERAPEUTICS, INC.S Sale	EXEC. VP AND CLO	SSale	−645 sh	$85.84	−$55.4K	106,017
2026-07-06	PTCTPTC THERAPEUTICS, INC.S Sale	EXEC. VP AND CLO	SSale	−745 sh	$86.38	−$64.4K	105,272
2026-07-06	PTCTPTC THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	EXEC. VP AND CLO	MExercise/Conversion	−2,226 sh	—	—	4,532
2026-07-06	PTCTPTC THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	EXEC. VP AND CLO	MExercise/Conversion	−2,813 sh	—	—	28,125
2026-06-17	PTCTPTC THERAPEUTICS, INC.M Exercise/Conversion	EXEC. VP AND CLO	MExercise/Conversion	+8,510 sh	$46.54	+$396K	113,722
2026-06-17	PTCTPTC THERAPEUTICS, INC.S Sale	EXEC. VP AND CLO	SSale	−6,600 sh	$78.50	−$518K	107,122
2026-06-17	PTCTPTC THERAPEUTICS, INC.S Sale	EXEC. VP AND CLO	SSale	−1,850 sh	$79.24	−$147K	105,272
2026-06-17	PTCTPTC THERAPEUTICS, INC.M Exercise/Conversion	EXEC. VP AND CLO	MExercise/Conversion	+2,012 sh	$46.54	+$93.6K	107,284
2026-06-17	PTCTPTC THERAPEUTICS, INC.S Sale	EXEC. VP AND CLO	SSale	−1,703 sh	$78.50	−$134K	105,581
2026-06-17	PTCTPTC THERAPEUTICS, INC.S Sale	EXEC. VP AND CLO	SSale	−309 sh	$79.25	−$24.5K	105,272
2026-06-17	PTCTPTC THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	EXEC. VP AND CLO	MExercise/Conversion	−8,510 sh	—	—	32,950
2026-06-17	PTCTPTC THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	EXEC. VP AND CLO	MExercise/Conversion	−2,012 sh	—	—	30,938
2026-05-15	PTCTPTC THERAPEUTICS, INC.M Exercise/Conversion	EXEC. VP AND CLO	MExercise/Conversion	+2,812 sh	$25.69	+$72.2K	108,024
2026-05-15	PTCTPTC THERAPEUTICS, INC.S Sale	EXEC. VP AND CLO	SSale	−2,356 sh	$72.08	−$170K	105,668
2026-05-15	PTCTPTC THERAPEUTICS, INC.S Sale	EXEC. VP AND CLO	SSale	−456 sh	$72.67	−$33.1K	105,212
2026-05-15	PTCTPTC THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	EXEC. VP AND CLO	MExercise/Conversion	−2,812 sh	—	—	19,689
2026-05-08	PTCTPTC THERAPEUTICS, INC.M Exercise/Conversion	EXEC. VP AND CLO	MExercise/Conversion	+2,740 sh	$46.54	+$128K	107,952
2026-05-08	PTCTPTC THERAPEUTICS, INC.S Sale	EXEC. VP AND CLO	SSale	−840 sh	$78.23	−$65.7K	107,112
2026-05-08	PTCTPTC THERAPEUTICS, INC.S Sale	EXEC. VP AND CLO	SSale	−1,900 sh	$79.31	−$151K	105,212
2026-05-08	PTCTPTC THERAPEUTICS, INC.M Exercise/Conversion	EXEC. VP AND CLO	MExercise/Conversion	+800 sh	$46.54	+$37.2K	106,012
2026-05-08	PTCTPTC THERAPEUTICS, INC.S Sale	EXEC. VP AND CLO	SSale	−200 sh	$78.00	−$15.6K	105,812
2026-05-08	PTCTPTC THERAPEUTICS, INC.S Sale	EXEC. VP AND CLO	SSale	−600 sh	$79.28	−$47.6K	105,212
2026-05-08	PTCTPTC THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	EXEC. VP AND CLO	MExercise/Conversion	−2,740 sh	—	—	42,260
2026-05-08	PTCTPTC THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	EXEC. VP AND CLO	MExercise/Conversion	−800 sh	—	—	41,460
2026-04-06	PTCTPTC THERAPEUTICS, INC.M Exercise/Conversion	EXEC. VP AND CLO	MExercise/Conversion	+2,265 sh	$39.42	+$89.3K	107,477
2026-04-06	PTCTPTC THERAPEUTICS, INC.S Sale	EXEC. VP AND CLO	SSale	−822 sh	$68.91	−$56.6K	106,655
2026-04-06	PTCTPTC THERAPEUTICS, INC.S Sale	EXEC. VP AND CLO	SSale	−1,443 sh	$69.75	−$101K	105,212
2026-04-06	PTCTPTC THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	EXEC. VP AND CLO	MExercise/Conversion	−2,265 sh	—	—	6,798
2026-02-19	PTCTPTC THERAPEUTICS, INC.S Sale	EXEC. VP AND CLO	SSale	−588 sh	$68.54	−$40.3K	107,643

Recent filings

Accepted (ET)
Oct 134
Boulding Mark Elliott0001578852-26-000026
SEC(opens sec.gov)
Oct 74
Boulding Mark Elliott0001578852-26-000024
SEC(opens sec.gov)
Aug 194
Boulding Mark Elliott0001578852-26-000022
SEC(opens sec.gov)
Jul 84
Boulding Mark Elliott0001578852-26-000020
SEC(opens sec.gov)

Companies

PTC THERAPEUTICS, INC.EXEC. VP AND CLOPTCT

Address

C/O PTC THERAPEUTICS, INC. 500 WARREN CORPORATE CENTER DRIVE

WARREN, NJ, 07059